CombiMatrix Signs a Co-Marketing Deal With Axon as its new 10K Chip Waits in Wings | GenomeWeb

While it has not set a date for the release of its next-generation microarray product, CombiMatrix, the Mulkiteo, Wash.-based life-sciences unit of Acacia Research, appears to be prepping for the launch of its 10,000-plus probe CustomArray product.

On Monday, the firm announced a co-marketing arrangement with Axon Instruments, which manufactures the widely distributed GenePix fluorescence scanner used for microarray imaging.

The agreement is non-exclusive and financial details were not disclosed in company’s statement.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.